drugset / Trial / NCT02634983
QVA Mechanistic Efficacy Study (Receptor Effects, Etc)
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study was to assess global ventilated lung volume in moderate to severe COPD patients using MRI lung imaging after treatment with QVA149 compared to placebo.
Timeline
- Start
- 2016-06-03
- Primary completion
- 2017-09-26
- Completion
- 2017-09-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QVA149 | Other / unclassified | 50 ug | Inhaled |
| Subject | QVA149 | Other / unclassified | 110 ug | Inhaled |